Search Result "PA-824"
3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Journal: Infectious Disorders - Drug Targets
Volume: 19 Issue: 2 Year: 2019 Page: 145-166
Author(s): Hemchandra K. Chaudhari,Akshata Pahelkar
New Anti-Tuberculosis Drugs with Novel Mechanisms of Action
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2008 Page: 1956-1967
Author(s): Emma C. Rivers, Ricardo L. Mancera
In Vitro and In Vivo Modeling of Tuberculosis Drugs and its Impact on Optimization of Doses and Regimens
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2881-2888
Author(s): Shashikant Srivastava, Tawanda Gumbo
Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and Leishmaniasis
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 23 Year: 2019 Page: 4454-4475
Author(s): Stephen Patterson,Alan H. Fairlamb
Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 3239-3262
Author(s): Clifton E. Barry, Helena I.M. Boshoff, Cynthia S. Dowd
Resistant TB: Newer Drugs and Community Approach
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 1 Year: 2011 Page: 27-37
Author(s): Dipti Gothi, Jyotsna M. Joshi
Novel Compounds and Drugs and Recent Patents in Treating Multidrug- Resistant and Extensively Drug-Resistant Tuberculosis
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 7 Issue: 2 Year: 2012 Page: 141-156
Author(s): Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn
Novel Agents in the Management of Mycobacterium Tuberculosis Disease
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2007 Page: 2000-2008
Author(s): P.J. Barry, T.M. OConnor
Current Status of Some Antituberculosis Drugs and the Development of new Antituberculous Agents with Special Reference to their In Vitro and In Vivo Antimicrobial Activities
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 3 Year: 2006 Page: 4047-4070
Author(s): Haruaki Tomioka
New Anti-Tuberculosis Drugs in Clinical Development: An Overview
Journal: Current Bioactive Compounds
Volume: 5 Issue: 2 Year: 2009 Page: 137-154
Author(s): Jerome Guillemont, Frederic Lieby-Muller, Nacer Lounis, Wendy Balemans, Anil Koul, Koen Andries